<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The myosin heavy chain (MyHC) is the molecular motor of muscle and forms the backbone of the sarcomere thick filaments </plain></SENT>
<SENT sid="1" pm="."><plain>Different MyHC isoforms are of importance for the physiological properties of different muscle fiber types </plain></SENT>
<SENT sid="2" pm="."><plain>Hereditary myosin <z:hpo ids='HP_0003198'>myopathies</z:hpo> have emerged as an important group of diseases with variable clinical and morphological expression depending on the mutated isoform and type and location of the mutation </plain></SENT>
<SENT sid="3" pm="."><plain>Dominant mutations in developmental MyHC isoform genes (MYH3 and MYH8) are associated with <z:hpo ids='HP_0005684'>distal arthrogryposis</z:hpo> syndromes </plain></SENT>
<SENT sid="4" pm="."><plain>Dominant or recessive mutations affecting the type IIa MyHC (MYH2) are associated with early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0003198'>myopathies</z:hpo> with variable <z:hpo ids='HP_0001324'>muscle weakness</z:hpo> and <z:hpo ids='HP_0000602'>ophthalmoplegia</z:hpo> as a consistent finding </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0003198'>Myopathies</z:hpo> with scapuloperoneal, distal or <z:hpo ids='HP_0003325'>limb-girdle muscle weakness</z:hpo> including entities, such as myosin storage <z:hpo ids='HP_0003198'>myopathy</z:hpo> and Laing distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> are the result of usually dominant mutations in the gene for slow/Î² cardiac MyHC (MYH7) </plain></SENT>
<SENT sid="6" pm="."><plain>Protein aggregation is part of the features in some of these <z:hpo ids='HP_0003198'>myopathies</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In myosin storage <z:hpo ids='HP_0003198'>myopathy</z:hpo> protein aggregates are formed by accumulation of myosin beneath the sarcolemma and between myofibrils </plain></SENT>
<SENT sid="8" pm="."><plain>In vitro studies on the effects of different mutations associated with myosin storage <z:hpo ids='HP_0003198'>myopathy</z:hpo> and Laing distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> indicate altered biochemical and biophysical properties of the light meromyosin, which is essential for thick filament assembly </plain></SENT>
<SENT sid="9" pm="."><plain>Protein aggregates in the form of tubulofilamentous inclusions in association with vacuolated muscle fibers are present at late stage of dominant myosin IIa <z:hpo ids='HP_0003198'>myopathy</z:hpo> and sometimes in Laing distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>These protein aggregates exhibit features indicating defective degradation of misfolded proteins </plain></SENT>
<SENT sid="11" pm="."><plain>In addition to protein aggregation and muscle fiber degeneration some of the myosin mutations cause functional impairment of the molecular motor adding to the pathogenesis of myosinopathies </plain></SENT>
</text></document>